4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0000905148-26-004399
Chief Legal Officer sold 294 shares at $1.99 ($585)
From the SEC's structured data for this filing
Trades in this filing
Miller Mary · Chief Legal Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-05 | Sale : show line 1 in the form | −294 | $1.99 | $585 | 81,715 | D |
| Open-market sales · 294 sh · avg $1.99 · $585 | ||||||
Loading xslF345X06/form4.xml…